Picture of Zydus Lifesciences logo

ZYDUSLIFE — Zydus Lifesciences News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

Brief: Refile-Zydus Lifesciences Says Receipt Of Warning Letter From USFDA For Baddi Facility

BRIEF-Refile-Zydus Lifesciences Says Receipt Of Warning Letter From USFDA For Baddi Facility

- Zydus Lifesciences Ltd ZYDU.NS:

  • ZYDUS LIFESCIENCES - RECEIPT OF WARNING LETTER FROM USFDA FOR BADDI FACILITY

  • ZYDUS LIFESCIENCES - BELIEVE THAT SAID WARNING LETTER WILL NOT IMPACT CURRENT OPERATIONS, SUPPLIES FROM BADDI SITE

  • ZYDUS LIFESCIENCES - TECHNICAL OBSERVATIONS REGARDING THE USE OF PURIFIED TALC

  • ZYDUS LIFESCIENCES - PURIFIED TALC THAT DID NOT MEET CURRENT UNITED STATES PHARMACOPEIA REQUIREMENTS

Further company coverage: ZYDU.NS


((Reuters.Briefs@thomsonreuters.com;))

Recent news on Zydus Lifesciences

See all news